Found: 75
Select item for more details and to access through your institution.
PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230901
- By:
- Publication type:
- Article
Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Applied Health Economics & Health Policy, 2018, v. 16, n. 1, p. 145, doi. 10.1007/s40258-017-0364-4
- By:
- Publication type:
- Article
Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Applied Health Economics & Health Policy, 2018, v. 16, n. 1, p. 133, doi. 10.1007/s40258-017-0350-x
- By:
- Publication type:
- Article
Comparison of [<sup>18</sup>F]DOPA and [<sup>68</sup>Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy.
- Published in:
- European Journal of Hybrid Imaging, 2022, v. 6, n. 1, p. 1, doi. 10.1186/s41824-022-00133-6
- By:
- Publication type:
- Article
Shortened duration whole body <sup>18</sup>F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function.
- Published in:
- EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00504-9
- By:
- Publication type:
- Article
Head‐to‐head comparison between <sup>18</sup>F‐DOPA PET/CT and <sup>68</sup>Ga‐DOTA peptides PET/CT in detecting intestinal neuroendocrine tumours: A systematic review and meta‐analysis.
- Published in:
- Clinical Endocrinology, 2021, v. 95, n. 4, p. 595, doi. 10.1111/cen.14527
- By:
- Publication type:
- Article
Optimization of parathyroid <sup>11</sup>C-choline PET protocol for localization of parathyroid adenomas in patients with primary hyperparathyroidism.
- Published in:
- EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0534-5
- By:
- Publication type:
- Article
Ultrashort Oncologic Whole-Body [<sup>18</sup>F]FDG Patlak Imaging Using LAFOV PET.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 10, p. 1652, doi. 10.2967/jnumed.124.267784
- By:
- Publication type:
- Article
<sup>18</sup>F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262368
- By:
- Publication type:
- Article
The new integrated nuclear medicine and radiology residency program in the Netherlands: why do residents choose to subspecialize in nuclear medicine and why not?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.261503
- By:
- Publication type:
- Article
<sup>18</sup>F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262368
- By:
- Publication type:
- Article
The new integrated nuclear medicine and radiology residency program in the Netherlands: why do residents choose to subspecialize in nuclear medicine and why not?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.261503
- By:
- Publication type:
- Article
<sup>18</sup>F-BMS986192 PET imaging of PD-L1 in metastatic melanoma patients with brain metastases treated with immune checkpoint inhibitors. A pilot study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262368
- By:
- Publication type:
- Article
The new integrated nuclear medicine and radiology residency program in the Netherlands: why do residents choose to subspecialize in nuclear medicine and why not?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.261503
- By:
- Publication type:
- Article
The new integrated nuclear medicine and radiology residency program in the Netherlands: why do residents choose to subspecialize in nuclear medicine and why not?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.261503
- By:
- Publication type:
- Article
The new integrated nuclear medicine and radiology residency program in the Netherlands: why do residents choose to subspecialize in nuclear medicine and why not?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.261503
- By:
- Publication type:
- Article
The new integrated nuclear medicine and radiology residency program in the Netherlands: why do residents choose to subspecialize in nuclear medicine and why not?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.261503
- By:
- Publication type:
- Article
The new integrated nuclear medicine and radiology residency program in the Netherlands: why do residents choose to subspecialize in nuclear medicine and why not?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.261503
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.239624
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.239624
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.239624
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.239624
- By:
- Publication type:
- Article
<sub>18</sub>F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.239624
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.239624
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.239624
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.239624
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.239624
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.239624
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 2, p. 1, doi. 10.2967/jnumed.119.239624
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Post-transplant Lymphoproliferative Disorders.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 1, p. 1, doi. 10.2967/jnumed.119.239624
- By:
- Publication type:
- Article
Image quality and activity optimizationinoncological <sup>18</sup>F‐FDGPET using the digital Biograph Vision PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.234351
- By:
- Publication type:
- Article
Image quality and semi-quantitative measurements of the Siemens Biograph Vision PET/CT: Initial experiences and comparison with Siemens Biograph mCT PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.227801
- By:
- Publication type:
- Article
Performance characteristics of the digital Biograph Vision PET/CT system.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.215418
- By:
- Publication type:
- Article
Performance Characteristics of the Digital Biograph Vision PET/CT System.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 7, p. 1031, doi. 10.2967/jnumed.118.215418
- By:
- Publication type:
- Article
Avenues to molecular imaging of dying cells: Focus on cancer.
- Published in:
- Medicinal Research Reviews, 2018, v. 38, n. 6, p. 1713, doi. 10.1002/med.21495
- By:
- Publication type:
- Article
Impact of patient motion on parametric PET imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1493, doi. 10.1007/s00259-024-06599-9
- By:
- Publication type:
- Article
Is work overload associated with diagnostic errors on <sup>18</sup>F-FDG-PET/CT?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 4, p. 1079, doi. 10.1007/s00259-023-06543-3
- By:
- Publication type:
- Article
Optimisation of scan duration and image quality in oncological <sup>89</sup>Zr immunoPET imaging using the Biograph Vision PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 8, p. 2258, doi. 10.1007/s00259-023-06194-4
- By:
- Publication type:
- Article
EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4652, doi. 10.1007/s00259-022-05919-1
- By:
- Publication type:
- Article
The integrated nuclear medicine and radiology residency program in the Netherlands: strengths and potential areas for improvement according to nuclear medicine physicians and radiologists.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 9, p. 3016, doi. 10.1007/s00259-022-05699-8
- By:
- Publication type:
- Article
Long axial field of view PET scanners: a road map to implementation and new possibilities.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 13, p. 4236, doi. 10.1007/s00259-021-05461-6
- By:
- Publication type:
- Article
Adrenal tracer uptake by <sup>18</sup>F-FDOPA PET/CT in patients with pheochromocytoma and controls.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1560, doi. 10.1007/s00259-019-04332-5
- By:
- Publication type:
- Article
Time for new imaging and therapeutic approaches in cardiac amyloidosis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 7, p. 1402, doi. 10.1007/s00259-019-04325-4
- By:
- Publication type:
- Article
Cushingoid facies on F-FDG PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 7, p. 1460, doi. 10.1007/s00259-014-2762-2
- By:
- Publication type:
- Article
Utility of F-FDG PET(/CT) in patients with systemic and localized amyloidosis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 7, p. 1095, doi. 10.1007/s00259-013-2375-1
- By:
- Publication type:
- Article
I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2012, v. 39, n. 10, p. 1609, doi. 10.1007/s00259-012-2187-8
- By:
- Publication type:
- Article
A dual-tracer approach using [<sup>11</sup>C]CH and [<sup>18</sup>F]FDG in HCC clinical decision making.
- Published in:
- EJNMMI Research, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13550-023-01024-y
- By:
- Publication type:
- Article
Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC.
- Published in:
- EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00879-x
- By:
- Publication type:
- Article
Myocardial Metastases on 6-[<sup>18</sup>F] fluoro-L-DOPA PET/CT: A Retrospective Analysis of 116 Serotonin Producing Neuroendocrine Tumour Patients.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0112278
- By:
- Publication type:
- Article
False-positive findings on 6-[<sup>18</sup>F]fluor-l-3,4- dihydroxyphenylalanine PET (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors.
- Published in:
- European Journal of Endocrinology, 2018, v. 179, n. 2, p. 125, doi. 10.1530/EJE-18-0321
- By:
- Publication type:
- Article